| 注册
首页|期刊导航|中国药物评价|HPLC-SEC法测定中药注射剂中残留大分子蛋白含量的研究

HPLC-SEC法测定中药注射剂中残留大分子蛋白含量的研究

齐越 鄢长余 姜范成 夏春鹏 赵月然

中国药物评价2025,Vol.42Issue(3):196-199,4.
中国药物评价2025,Vol.42Issue(3):196-199,4.

HPLC-SEC法测定中药注射剂中残留大分子蛋白含量的研究

Determination of Macromolecular Protein Residues in Traditional Chinese Medicine Injections by HPLC-SEC

齐越 1鄢长余 2姜范成 2夏春鹏 3赵月然2

作者信息

  • 1. 江苏省徐州医药高等职业学校药学技术系,江苏徐州 221116
  • 2. 大连市检验检测认证技术服务中心,辽宁大连 116021
  • 3. 辽宁中医药大学药学院,辽宁大连 116600
  • 折叠

摘要

Abstract

Objective:To establish a HPLC-SEC method for determination of macromolecular protein residues in traditional Chinese medicine injections(TCMIs).Methods:The analysis was performed on the TSK GEL G2000SWxl(7.8 mm ×300 mm,5 μm)column at the temperature of 35 ℃.The mobile phase was composed of acetonitrile and 0.08%trifluoroacetic acid(5∶95,v/v).The flow rate was 0.8 mL·min-1 and the detection wavelength was set at 214 nm.Results:The protein reference substances were used to validate the method,including serum albumin(bovine),lysozyme,insulin human and thymic peptide α1.The molecular weight range of the proteins was 66 400-3 108 Da.The linear relationship was good in the range of 0.381 2-3.812 μg(r>0.999)as lysozyme was used as the reference substance to calculate the relative content.The precision,repeatability,and stability of the method were good(RSD≤2.0%).The relative content of macromolecular protein was detected in 2 out of 5 batches of TCMIs and the content was 25.7 μg·mL-1 and 32.6 μg·mL-1.Conclusion:The HPLC-SEC method was simple,sensitive and reproducible,and can be used for the determination of macromolecular protein residues in TCMIs.It provided an effective method for governing the quality of TCMIs.

关键词

高效液相色谱-体积排阻法/中药注射剂/离心过滤/大分子蛋白残留/溶菌酶

Key words

High-performance size exclusion chromatography(HPLC-SEC)/Traditional chinese medicine injections(TCMIs)/Centrifugal filter/Macromolecular protein residues/Lysozyme

分类

医药卫生

引用本文复制引用

齐越,鄢长余,姜范成,夏春鹏,赵月然..HPLC-SEC法测定中药注射剂中残留大分子蛋白含量的研究[J].中国药物评价,2025,42(3):196-199,4.

基金项目

江苏省药品监督管理局科研计划课题(202305) (202305)

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文